Acoustic Neuroma Market Report 2026

Acoustic Neuroma Market Overview

• Acoustic Neuroma market size has reached to $1.97 billion in 2025 • Expected to grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Healthcare Sector Investments Fueling Growth Opportunities In The Acoustic Neuroma Market • Market Trend: Advancements In Radiosurgery Technology Improve Precision In Treating Central Nervous System Tumors • North America was the largest region in 2025.

What Is Covered Under Acoustic Neuroma Market?

Acoustic neuroma, also known as vestibular schwannoma, is a non-cancerous tumor that develops on the vestibular nerve connecting the inner ear to the brain responsible for transmitting balance and hearing information to the brain. Acoustic neuromas typically grow slowly and do not spread to other body parts, with symptoms of hearing loss, tinnitus (ringing in the ear), dizziness, imbalance, facial numbness or weakness, and problems with coordination. The main types of acoustic neuroma are unilateral vestibular schwannomas and bilateral vestibular schwannomas. Vestibular schwannomas occurring unilaterally denote acoustic neuromas arising on one side of the vestibulocochlear nerve, influencing both hearing and balance functions. The treatment includes drugs, anticonvulsants, radiation therapy, proton therapy, and stereotactic radiosurgery, and diagnosis is done by magnetic resonance imaging (MRI), computed tomography scan (CT-Scan), and hearing tests. The end users include hospitals, clinics, and surgical centers.

What Is The Acoustic Neuroma Market Growth Forecast?

The acoustic neuroma market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to technological advancements in mri and ct-scan, growth of proton therapy and stereotactic radiosurgery, rising investments in hospitals and surgical centers, increasing patient awareness and early diagnosis, expansion of specialized treatment centers. Major trends in the forecast period include increasing adoption of advanced imaging techniques, rising preference for minimally invasive treatments, growth in proton therapy and stereotactic radiosurgery, expansion of personalized treatment approaches, increasing awareness about vestibular schwannoma symptoms.

Global Acoustic Neuroma Market Segmentation

1) By Type: Unilateral Vestibular Schwannomas, Bilateral Vestibular Schwannomas 2) By Treatment Type: Radiation Therapy, Proton Therapy, Stereotactic Radiosurgery 3) By Diagnosis Type: Magnetic Resonance Imaging (MRI), Hearing Tests 4) By End User: Hospitals, Surgical Centers Subsegments: 1) By Unilateral Vestibular Schwannomas: Small Unilateral Vestibular Schwannomas, Medium Unilateral Vestibular Schwannomas, Large Unilateral Vestibular Schwannomas 2) By Bilateral Vestibular Schwannomas: Familial Bilateral Vestibular Schwannomas, Sporadic Bilateral Vestibular Schwannomas

What Is The Driver Of The Acoustic Neuroma Market?

The rising investment in the healthcare sector is expected to propel the growth of the acoustic neuroma market going forward. The healthcare sector refers to a wide range of services and facilities dedicated to promoting health, providing medical care, and improving overall well-being for individuals and populations. Investment in the healthcare sector is due to increasing demand, technological innovation, regulatory changes, and global health challenges. Investments in the healthcare sector support innovation in diagnostics and treatments for acoustic neuroma conditions, enhancing patient outcomes and quality of life. For instance, in April 2025, according to the Office for National Statistics, a UK-based independent producer of official statistics, in 2024, the UK’s healthcare spending reached around £317 billion, reflecting a 6.5% nominal increase compared with 2023. Therefore, the rising investment in the healthcare sector is driving the growth of the acoustic neuroma industry.

Key Players In The Global Acoustic Neuroma Market

Major companies operating in the acoustic neuroma market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceuticals Industries Ltd, General Electric Company, Siemens Healthineers, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Shimadzu Corporation, Varian Medical Systems, Elekta AB, Medtronic plc, Olympus Corporation, Cochlear Limited, Brainlab AG, Natus Medical Incorporated, Abbott Laboratories

Global Acoustic Neuroma Market Trends and Insights

Major companies operating in the acoustic neuroma market are focusing on developing advanced solutions, such as high-precision image-guided delivery, to enhance treatment accuracy, minimize damage to surrounding tissues, and improve patient outcomes. High-precision image-guided delivery refers to a technological feature in radiosurgery that allows real-time targeting and tracking of tumors, ensuring precise radiation delivery to the affected area. For instance, in April 2025, Accuray Incorporated, a US-based medical device company specializing in advanced radiosurgery systems, announced new clinical data on the CyberKnife System, highlighting its broad capabilities in delivering SRS and SBRT. Designed to treat central nervous system (CNS) tumors, including acoustic neuroma, the system provides noninvasive, targeted treatment options that improve safety and clinical efficacy.

What Are Latest Mergers And Acquisitions In The Acoustic Neuroma Market?

In April 2024, Elekta AB, a Sweden-based medical technology company that offers treatment options for acoustic neuroma, collaborated with MIM Software Inc. to integrate Elekta’s radiation therapy platforms with MIM’s vendor-agnostic auto-contouring and treatment-planning software. Through this collaboration, Elekta aims to accelerate innovation in radiation oncology applications, improve clinical workflows, increase treatment precision, and enhance patient experience by reducing planning time and optimizing radiotherapy delivery for conditions such as acoustic neuroma. MIM Software Inc. is a US-based provider of medical imaging and AI-driven treatment-planning solutions.

Regional Outlook

North America was the largest region in the acoustic neuroma market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acoustic Neuroma Market?

The acoustic neuroma market consists of revenues earned by entities by providing services such as neurosurgery, hearing tests, auditory rehabilitation, and counseling and support services for patients and families. The market value includes the value of related goods sold by the service provider or included within the service offering. The acoustic neuroma market also includes sales of hearing aids, surgical instruments, balance therapy equipment, and assistive listening devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acoustic Neuroma Market Report 2026?

The acoustic neuroma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acoustic neuroma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.